Hall, Brantley http://orcid.org/0000-0001-7553-8209
Levy, Sophia http://orcid.org/0009-0003-8055-3202
Dufault-Thompson, Keith http://orcid.org/0000-0002-0991-2255
Arp, Gabriela http://orcid.org/0009-0004-3819-5648
Zhong, Aoshu http://orcid.org/0000-0002-5793-3990
Ndjite, Glory Minabou
Weiss, Ashley
Braccia, Domenick
Jenkins, Conor http://orcid.org/0000-0002-2333-9184
Grant, Maggie R. http://orcid.org/0000-0003-2607-9493
Abeysinghe, Stephenie
Yang, Yiyan
Jermain, Madison D. http://orcid.org/0009-0005-1979-5426
Wu, Chih Hao
Ma, Bing http://orcid.org/0000-0002-3488-2393
Jiang, Xiaofang http://orcid.org/0000-0002-0955-8284
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Intramural Research Program, National Institutes of Health
Startup funding, University of Maryland
Article History
Received: 15 March 2023
Accepted: 7 November 2023
First Online: 3 January 2024
Competing interests
: B.H. is the inventor on a provisional patent filed by the University of Maryland for the use of the enzyme bilirubin reductase. The other authors declare no competing interests.